国际皮肤性病学杂志    2001 27 (5): 259-262   ISSN: 2096-5540  CN: 32-1880/R   霉酚酸酯在皮肤病治疗中的应用 陈红清综述1, 吴志华审校2 1. 广州市皮肤病防治所; 2. 广东医学院皮肤性病研究所 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Lipsky JJ. Mycophenolate mofetil. Lancet, 1996,348(9038):1357-1359. [2] Laliberte J, Yee A, Xiong Y, et al. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood, 1998,91(8):2896-2904. [3] Blaheta RA, Lockel K, Wittig B, et al. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol, 1998,6(4):251-259. [4] Penny MJ, Boyd RA, Hall BM. Mycophenolate mofetil prevents the induction of active Heymann nephritis:association with Th2 cytokine inhibiton. J Am Soc Nephrol, 1998,9(12):2272-2282. [5] Hood KA, Zarembski DG. Mycophenolate mofetil:a unique immunosuppressive agent. Am J Health Syst Pharm, 1997,54(3):285-294. [6] Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet, 1998,34(6):429-455. [7] Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol, 1999, 135(1):54-56. [8] Bredlich RO, Grundmann-Kollmann M, Behrens S, et al. Mycophenolate mofetil monotherapy for pemphigus vulgaris. Br J Dermatol, 1999,141(5):934. [9] Grundmann-Kollmann M, Korting HC, Behrens S, et al. Mycophenolate mofetil:a new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol, 1999,40(6 Pt 1):957-960. [10] Nousari HC, Griffin WA, Anhalt GJ, et al. Successful therapy for bullous pemphigoid with mycophenolate mofetil. J Am Acad Dermatol, 1998,39(3):497-498. [11] Nousari HC, Sragovich A, Kimyai-Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. JAm Acad Dermatol,1999,40(2 Pt 1):265-268. [12] Haufs MG, Beissert S, Grabbe S, et al. Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol, 1998,138(1):179-181. [13] Geilen CC, Tebbe B, Garcia-Bartels C, et al. Successful treatment of erythrodermic psoriasis with mycophenolate mofetil. Br J Dermatol, 1998, 138(6):1101-1102. [14] Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis, 1998, 32(2):318-322. [15] Dooley MA. Cosio FG, Nachman PH, et al. Mycophenolate mofetil therapy in lupus nephritis:clinical observations. J Am Soc Nephrol, 1999, 10(4):893-839. [16] Gaubitz M, Schorat A, Schotte H, et al. Mycophenolate mofetil for the treatment of systemic lupus erythematosus:an open pilot trial. Lupus,1999,8(9):731-736. [17] Grundmarn-Kollmann M, Korting HC, Behrens S, et al. Successfully treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol, 1999,141(1):175-176. [18] Nousari HC, Goyal S, Anhalt GJ, et al. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol, 1999,135(11):1420-1421. [19] Gnmdmann-Kollmann M, Behrens S, Gruss C, et al. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVAl phototherapy. J Am Acad Dermatol, 2000,42(1 Pt 1):134-136. [20] Nousari HC, Lynch W, Anhalt GJ, et al. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol, 1998,134(12):1509-1511. [21] Enk AH, Knop J. Treatment of relapsing idiopathic nodular panniculitis(Pfeifer-Weber-Christian disease) with mycophenolate mofetil. J Am Acad Dermatol, 1998,39(3):508-509. [22] Williams JV, Marks JG, Billingsley EM, et al. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol,2000,142(3):506-508. [23] Schattenkirchner S, Eming S, Hunelmann N, et al. Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting. Br J Dermatol, 1999,141(5):932-933. 通讯作者: